Read Editorial with D2G – Ep 497
Essential dry run: On COVID-19 vaccination drive
READ BEFORE YOU PROCEED: D2G wears no responsibility of the views published here by the respective Author. This Editorial is used here for Study Purpose. Students are advised to learn the word-meaning, The Art of Writing Skills and understand the crux of this Editorial.
Meanings are given in BOLD
In the next couple of weeks, Phase-3 data of two COVID-19 vaccines tested by Indian manufacturers are expected to be submitted for emergency use approval. If even one of the vaccines gets the approval, a countrywide rollout ( to introduce (something, such as a new product)) to immunise the four high-risk groups starting with healthcare workers will begin soon thereafter ( After that ) .
India has been vaccinating millions of young children with a variety of vaccines each year and hence has the entire system in place to roll out any new vaccine under the universal immunisation programme. But this is the first time a vaccine to be administered ( to control or manage something ) outside the programme and specifically for adults is to be rolled out.
Since several aspects of the COVID-19 vaccination programme are new — vaccinating millions of adults belonging to specific groups, administering two doses of the vaccine a few weeks apart, and the process of enrolling ( to become or to make somebody a member of a club, school, etc. ) the recipients and rolling out the immunisation programme — the government has rightly decided to undertake a dry run for vaccine administration.
The dry run is expected to be initiated this week in four States — Andhra Pradesh, Assam, Gujarat, and Punjab. It will allow the administrators to test the vaccination process and check the usage of the Co-WIN IT platform for management of the entire vaccination process including data entry, allocation of date and time and a drill of session sites with test beneficiaries ( a person who gains as a result of something, especially money or property) .
The linkages ( link or connection between them) between planning, implementation and reporting mechanisms will also be tested. Since four high-risk groups have been prioritised (to put tasks, problems, etc. in order of importance, so that you can deal with the most important first) to receive the vaccine, the first task is to register the recipients ( a person who receives something ) on the Co-WIN platform.
Unlike vaccinating children under the universal immunisation programme, the COVID-19 vaccine will be administered to 100 adults at each designated ( to give something a name to show that it has a particular purpose ) site on a pre-defined date and time. Prior to vaccination, the bona fide of the registered adults are to be determined. The IT platform has to generate the date and time when people can receive the second dose. When more than one vaccine becomes available, it is essential to ensure ( to make sure that something happens or is definite ) that people receive the same vaccine twice.
Checking and reporting of all adverse ( making something difficult for somebody ) events immediately and days after the vaccination is essential, all the more as no COVID-19 vaccine has undergone long-term follow-up for safety during the trial. Both the vaccines that are at an advanced stage of testing in India do not require ultra-low temperature for delivery and storage.
Hence, the existing facilities of the universal immunisation programme in most districts can be used for storing ( to keep something or a supply of something for future use ) the vaccines. As the plan is to vaccinate 300 million people in the four high-risk groups, 600 million doses will be required.
This exercise should therefore look at creating additional storage capacity at these facilities to store millions of COVID-19 vaccines, as facilities for vaccine storage cannot be dedicated ( giving a lot of your energy, time, efforts, etc. to something that you believe to be important ) to a single vaccine.